Stories

  • CRISPR Main Story - SM

    06-Jan-2015
    Can We Edit Our Genes to Fight Disease?

    Novartis adopts a CRISPR-based system to modify DNA in human cells for patients.

  • CRISPR 1 - SM

    06-Jan-2015
    A Boost for Immunotherapy

    T cells engineered to recognize cancer help some patients fight the disease. Researchers hope to expand on the experimental treatment with CRISPR-based gene editing.

  • CRISPR 2 - SM

    06-Jan-2015
    Rebuilding Blood

    Team explores gene therapy for hematological disorders.

  • Neglected Tropical Diseases - Thumb

    05-Jan-2015
    Neglected Tropical Diseases Take Priority

    The Novartis Institutes for Tropical Diseases focuses exclusively on neglected tropical diseases such as dengue fever, malaria, and African sleeping sickness.